BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10993733)

  • 1. II. Structure and specificity of the interaction between the FHA2 domain of Rad53 and phosphotyrosyl peptides.
    Wang P; Byeon IJ; Liao H; Beebe KD; Yongkiettrakul S; Pei D; Tsai MD
    J Mol Biol; 2000 Sep; 302(4):927-40. PubMed ID: 10993733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of the FHA1 domain of yeast Rad53 and identification of binding sites for both FHA1 and its target protein Rad9.
    Liao H; Yuan C; Su MI; Yongkiettrakul S; Qin D; Li H; Byeon IJ; Pei D; Tsai MD
    J Mol Biol; 2000 Dec; 304(5):941-51. PubMed ID: 11124038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solution structure of the yeast Rad53 FHA2 complexed with a phosphothreonine peptide pTXXL: comparison with the structures of FHA2-pYXL and FHA1-pTXXD complexes.
    Byeon IJ; Yongkiettrakul S; Tsai MD
    J Mol Biol; 2001 Nov; 314(3):577-88. PubMed ID: 11846568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure and function of a new phosphopeptide-binding domain containing the FHA2 of Rad53.
    Liao H; Byeon IJ; Tsai MD
    J Mol Biol; 1999 Dec; 294(4):1041-9. PubMed ID: 10588905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ligand specificity of yeast Rad53 FHA domains at the +3 position is determined by nonconserved residues.
    Yongkiettrakul S; Byeon IJ; Tsai MD
    Biochemistry; 2004 Apr; 43(13):3862-9. PubMed ID: 15049693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solution structures of two FHA1-phosphothreonine peptide complexes provide insight into the structural basis of the ligand specificity of FHA1 from yeast Rad53.
    Yuan C; Yongkiettrakul S; Byeon IJ; Zhou S; Tsai MD
    J Mol Biol; 2001 Nov; 314(3):563-75. PubMed ID: 11846567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the N-terminal forkhead-associated domain in the cell cycle checkpoint function of the Rad53 kinase.
    Pike BL; Hammet A; Heierhorst J
    J Biol Chem; 2001 Apr; 276(17):14019-26. PubMed ID: 11278522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diverse but overlapping functions of the two forkhead-associated (FHA) domains in Rad53 checkpoint kinase activation.
    Pike BL; Yongkiettrakul S; Tsai MD; Heierhorst J
    J Biol Chem; 2003 Aug; 278(33):30421-4. PubMed ID: 12805372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are trigger sequences essential in the folding of two-stranded alpha-helical coiled-coils?
    Lee DL; Lavigne P; Hodges RS
    J Mol Biol; 2001 Feb; 306(3):539-53. PubMed ID: 11178912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase.
    Bradshaw JM; Mitaxov V; Waksman G
    J Mol Biol; 1999 Nov; 293(4):971-85. PubMed ID: 10543978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FHA domain boundaries of the dun1p and rad53p cell cycle checkpoint kinases.
    Hammet A; Pike BL; Mitchelhill KI; Teh T; Kobe B; House CM; Kemp BE; Heierhorst J
    FEBS Lett; 2000 Apr; 471(2-3):141-6. PubMed ID: 10767410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Location-specific functions of the two forkhead-associated domains in Rad53 checkpoint kinase signaling.
    Tam AT; Pike BL; Heierhorst J
    Biochemistry; 2008 Mar; 47(12):3912-6. PubMed ID: 18302321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase.
    Siegal G; Davis B; Kristensen SM; Sankar A; Linacre J; Stein RC; Panayotou G; Waterfield MD; Driscoll PC
    J Mol Biol; 1998 Feb; 276(2):461-78. PubMed ID: 9512716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative mode of binding to phosphotyrosyl peptides by Src homology-2 domains.
    Qin C; Wavreille AS; Pei D
    Biochemistry; 2005 Sep; 44(36):12196-202. PubMed ID: 16142918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The FHA domain is a modular phosphopeptide recognition motif.
    Durocher D; Henckel J; Fersht AR; Jackson SP
    Mol Cell; 1999 Sep; 4(3):387-94. PubMed ID: 10518219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphothreonine recognition comes into focus.
    Zhou MM
    Nat Struct Biol; 2000 Dec; 7(12):1085-7. PubMed ID: 11101883
    [No Abstract]   [Full Text] [Related]  

  • 17. The molecular basis of FHA domain:phosphopeptide binding specificity and implications for phospho-dependent signaling mechanisms.
    Durocher D; Taylor IA; Sarbassova D; Haire LF; Westcott SL; Jackson SP; Smerdon SJ; Yaffe MB
    Mol Cell; 2000 Nov; 6(5):1169-82. PubMed ID: 11106755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structures of the human p56lck SH2 domain in complex with two short phosphotyrosyl peptides at 1.0 A and 1.8 A resolution.
    Tong L; Warren TC; King J; Betageri R; Rose J; Jakes S
    J Mol Biol; 1996 Mar; 256(3):601-10. PubMed ID: 8604142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissection of the energetic coupling across the Src SH2 domain-tyrosyl phosphopeptide interface.
    Lubman OY; Waksman G
    J Mol Biol; 2002 Feb; 316(2):291-304. PubMed ID: 11851339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PhosphoThr peptide binding globally rigidifies much of the FHA domain from Arabidopsis receptor kinase-associated protein phosphatase.
    Ding Z; Lee GI; Liang X; Gallazzi F; Arunima A; Van Doren SR
    Biochemistry; 2005 Aug; 44(30):10119-34. PubMed ID: 16042389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.